| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |